NOVONIX Ltd Files Form 6-K for June 2024

Ticker: NVNXF · Form: 6-K · Filed: Jun 7, 2024 · CIK: 1859795

Sentiment: neutral

Topics: sec-filing, 6-K, reporting

Related Tickers: NVX

TL;DR

NOVONIX filed a routine 6-K, confirming 20-F filing and no major news.

AI Summary

NOVONIX Limited filed a Form 6-K on June 7, 2024, reporting information for the month of June 2024. The filing indicates that NOVONIX is a foreign private issuer and will file its annual reports under cover of Form 20-F. The document primarily serves as an update and does not contain specific financial transactions or material events beyond its reporting nature.

Why It Matters

This filing confirms NOVONIX's status as a foreign private issuer and its reporting schedule with the SEC, which is important for investors tracking its compliance and disclosure practices.

Risk Assessment

Risk Level: low — This filing is a routine report and does not contain new material information that would typically impact risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2024.

What is NOVONIX Limited's filing status with the SEC?

NOVONIX Limited is a foreign private issuer and indicates it files annual reports under cover of Form 20-F.

What is the principal executive office address for NOVONIX Limited?

The principal executive office is located at Level 38, 71 Eagle Street, Brisbane, QLD 4000, Australia.

Does NOVONIX Limited file its annual reports using Form 40-F?

No, the filing explicitly indicates that NOVONIX Limited files annual reports under cover of Form 20-F, not Form 40-F.

What is the SIC code for NOVONIX Limited?

The Standard Industrial Classification (SIC) code for NOVONIX Limited is 3690, which corresponds to Miscellaneous Electrical Machinery, Equipment & Supplies.

Filing Stats: 194 words · 1 min read · ~1 pages · Grade level 12.4 · Accepted 2024-06-07 17:16:06

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: June 7, 2024

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing